Related references
Note: Only part of the references are listed.The effect of weight loss surgery on the severity of psoriasis
E. W. Hossler et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
Body weight increment in patients treated with infliximab for plaque psoriasis
V. Florin et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2013)
Obesity and the risk of psoriatic arthritis: a population-based study
Thorvardur Jon Love et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Long-term efficacy of ustekinumab in moderate-to-severe psoriasis
A. B. Kimball et al.
BRITISH JOURNAL OF DERMATOLOGY (2012)
Weight Reduction Alone May Not Be Sufficient to Maintain Disease Remission in Obese Patients with Psoriasis: A Randomized, Investigator-Blinded Study
Micol Del Giglio et al.
DERMATOLOGY (2012)
Prospective assessment of body weight and body composition changes in patients with psoriasis receiving anti-TNF-α treatment
Laura Di Renzo et al.
DERMATOLOGIC THERAPY (2011)
Obesity and psoriasis: body weight and body mass index influence the response to biological treatment
L. Puig
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2011)
Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis
Christopher E. M. Griffiths et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Anti-tumour necrosis factor-α therapy increases body weight in patients with chronic plaque psoriasis:: a retrospective cohort study
P. Gisondi et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2008)
Effect of anti-tumor necrosis factor-α therapies on body mass index in patients with psoriasis
Rosita Saraceno et al.
PHARMACOLOGICAL RESEARCH (2008)
Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study
P. Gisondi et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
Impact of obesity and smoking on psoriasis presentation and management
MD Herron et al.
ARCHIVES OF DERMATOLOGY (2005)
Body weight, body composition, and bone turnover changes in patients with spondyloarthropathy receiving anti-tumour necrosis factor α treatment
K Briot et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Impact of infliximab on serum leptin levels in patients with Crohn's disease
D Franchimont et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)